LINC00703 Acts as a Tumor Suppressor via Regulating miR-181a/KLF6 Axis in Gastric Cancer
- Author:
Haiyang YANG
1
;
Minqi PENG
;
Yanjiao LI
;
Renjie ZHU
;
Xiang LI
;
Zhengjiang QIAN
Author Information
- Publication Type:Original Article
- Keywords: LincRNAs; KLF6; miRNA sponge; Gastric cancer
- MeSH: Animals; Apoptosis; Binding Sites; Blotting, Western; Cell Line; Cell Proliferation; Gene Expression; Heterografts; Immunoprecipitation; In Vitro Techniques; Mice; Mice, Nude; Real-Time Polymerase Chain Reaction; RNA, Long Noncoding; RNA-Binding Proteins; Stomach Neoplasms
- From:Journal of Gastric Cancer 2019;19(4):460-472
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: Long noncoding RNA 00703 (LINC00703) was found originating from a region downstream of Kruppel-like factor 6 (KLF6) gene, having 2 binding sites for miR-181a. Since KLF6 has been reported as a target of miR-181a in gastric cancer (GC), this study aims to investigate whether LINC00703 regulates the miR-181a/KLF6 axis and plays a functional role in GC pathogenesis.MATERIALS AND METHODS: GC tissues, cell lines, and nude mice were included in this study. RNA binding protein immunoprecipitation (RIP) and pull-down assays were used to evaluate interaction between LINC00703 and miR-181a. Quantitative real-time polymerase chain reaction and western blot were applied for analysis of gene expression at the transcriptional and protein levels. A nude xenograft mouse model was used to determine LINC00703 function in vivo.RESULTS: We revealed that LINC00703 competitively interacts with miR-181a to regulate KLF6. Overexpression of LINC00703 inhibited cell proliferation, migration/invasion, but promoted apoptosis in vitro, and arrested tumor growth in vivo. LINC00703 expression was found to be decreased in GC tissues, which was positively correlated with KLF6, but negatively with the miR-181a levels.CONCLUSIONS: LINC00703 may have an anti-cancer function via modulation of the miR-181a/KLF6 axis. This study also provides a new potential diagnostic marker and therapeutic target for GC treatment.
